D-Penamine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Penicillamine.
Product ID | 0378-0709_0a7a279d-b6a2-41a6-a7cb-13bd83177f60 |
NDC | 0378-0709 |
Product Type | Human Prescription Drug |
Proprietary Name | D-Penamine |
Generic Name | Penicillamine |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2018-11-15 |
Marketing End Date | 2020-06-30 |
Marketing Category | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE / UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | PENICILLAMINE |
Active Ingredient Strength | 125 mg/1 |
Pharm Classes | Antirheumatic Agent [EPC] |
NDC Exclude Flag | N |
Marketing Start Date | 2018-11-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | Unapproved drug for use in drug shor |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-11-15 |
Ingredient | Strength |
---|---|
PENICILLAMINE | 125 mg/1 |
SPL SET ID: | 4b73a8e2-b66d-4ce3-bd82-f250c96bdf60 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0378-0709 | D-Penamine | Penicillamine |
25010-705 | Cuprimine | penicillamine |
0037-4401 | Depen | Penicillamine |
0254-2000 | penicillamine | penicillamine |
0591-4171 | Penicillamine | Penicillamine |
43598-634 | Penicillamine | Penicillamine |
43975-309 | Penicillamine | Penicillamine |
49884-146 | Penicillamine | penicillamine |
51991-974 | Penicillamine | Penicillamine |
60505-4696 | Penicillamine | Penicillamine |
62559-970 | Penicillamine | Penicillamine |
68475-201 | Penicillamine | Penicillamine |
68682-020 | penicillamine | penicillamine |
70010-907 | Penicillamine | Penicillamine |
70748-153 | Penicillamine | Penicillamine |
71205-916 | Penicillamine | Penicillamine |